SEC Form 4 research
| Issuer | BioNexus Gene Lab Corp |
|---|---|
| Tickers | BGLC |
| Reporting owners | 15 |
| Officers and directors | 0 |
| Last public filing | 2026-08-15 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-08-14 | 2026-08-13 | Tan Lee Su-Leng | A | 338,709 | Not reported | Not reported |
| 2026-08-14 | 2026-08-13 | Yap Chee Keong | A | 32,258 | Not reported | Not reported |
| 2026-08-14 | 2026-08-13 | Bin Abdul Hamid Muhammad Azrul | A | 32,258 | Not reported | Not reported |
| 2026-08-14 | 2026-08-13 | Chong Set Fui | A | 96,774 | Not reported | Not reported |
| 2026-08-14 | 2026-08-13 | Low Jook Yuen | A | 16,129 | Not reported | Not reported |
No directory officers or directors published yet.
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.